| Financial Year |
March 31 2023 |
| Monetary Funds |
771,171,110.81 |
| Held-for-trading Financial Assets |
717,970,334.76 |
| Notes Receivable |
-- |
| Accounts Receivable |
522,030,548.44 |
| Advances to Suppliers |
426,019,546.49 |
| Other Receivables |
20,183,615.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,022,343,944.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
27,711,902.03 |
| Total Current Assets |
3,507,431,002.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
17,241,727.19 |
| Investment Properties |
191,137,271.17 |
| Fixed Assetes |
2,853,525.32 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,000,000.00 |
| R&D expenses |
-- |
| Goodwill |
177,651,626.69 |
| Long-Term Deferred and Prepaid Expenses |
10,192,155.42 |
| Deferred Income Tax Assets |
65,970,705.35 |
| Other Non-Current Assets |
269,556.00 |
| Sub-Total of Non-Current Assets |
727,711,392.70 |
| Total Assets |
4,235,142,395.15 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
5,211,929.33 |
| Accounts Received In Advance |
305,372.50 |
| Employee Compensation Payable |
2,292,651.19 |
| Taxes Payable |
25,349,404.08 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
100,998,757.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
37,897,434.96 |
| Other Current Liabilities |
599,542.42 |
| Sub-Total of Current Liabilities |
195,621,245.10 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
29,160,093.20 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
91,925,072.80 |
| Total Liabilities |
287,546,317.90 |
| Paid-In Capital(Or Share Stock) |
930,354,651.00 |
| Capital Surplus |
4,932,058,878.53 |
| Surplus Reserve |
33,769,220.36 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,116,165,707.37 |
| Minority Stockholder's Interest |
167,579,034.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,780,017,042.52 |
| Owner's Equity（Stockholder's Equity） |
3,947,596,077.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,235,142,395.15 |
